One-year retention rate of ixekizumab in patients with psoriatic arthritis and axial spondyloarthritis: Real-world data from the BIOBADASER registry Clementina López-Medina; Lucía Otero-Varela; Fernando Sánchez-Alonso; Vega Jovaní; Lorena Expósito-Pérez; Sheila Melchor-Díaz; Yanira Pérez-Vera; Paula Pretel-Ruiz; Javier Manero; Antonio Mera-Varela; Lourdes Mateo; Dolores Ruiz-Montesino; José Andrés Lorenzo-Martín; Teresa Pedraz-Penalva; Isabel Castrejón;

Guía de práctica clínica para el tratamiento de la espondiloartritis axial y la artritis psoriásica. ESPOGUÍA 2024 Juan D. Cañete; Petra Díaz del Campo Fontecha;

Do patients with axial spondyloarthritis with active disease suffer from greater disease burden and work impairment? Results from the International Map of Axial Spondyloarthritis (IMAS) Marco Garrido-Cumbrera; Denis Poddubnyy; Fernando Sommerfleck; Christine Bundy; Souzi Makri; José Correa-Fernández; Shashank Akerkar; Jo Lowe; Elie Karam; Victoria Navarro-Compán;